2026-07-02
No AI summary for this filing type
View Full Filing (SEC EDGAR)TENX
Tenax Therapeutics INC
+$256.8M
Net Activity
Institutions Holding
80
Popularity Rank
#4957
Avg Weight
0.30%
Total Value
$341.3M
Ownership Trend
80 institutions currently hold TENX, with 57 net buyers and 6 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Significantly Increased
Based on recent trading activity
Net Selling Institutions
6
Net Buying Institutions
57
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$304.0M
Total Buy Value
$11.1M
Total Sell Value
New buy31
Trim5
Add26
Sold out1
57
Net Buyers
6
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
0
Active 5%+ Holders
Data as of 2026-07-17
| Reporting Person | Type | Filing Date | % of Class |
|---|---|---|---|
| Millennium Management LLC | 13G/A | 2026-07-17 | 3.3% |
Material Events (8-K)
2
Filings (14d)
Data as of 2026-07-02
2026-06-30
Tenax Therapeutics entered into a supply agreement with Orion Corporation, making Orion the primary manufacturer and supplier of the oral version of its heart drug levosimendan. At the same time, the companies amended their license agreement to push back the deadline for U.S. regulatory approval to December 31, 2035. The supply deal runs for five years after the first delivery, with automatic three-year renewals unless either party gives 24 months' notice to stop.
View Full Filing (SEC EDGAR)FAQ
Who are the top institutional investors holding TENAX THERAPEUTICS INC (TENX)?
Major stakeholders currently include Price T Rowe Associates INC /md/ ($47.2M), Janus Henderson Group PLC ($29.1M), Venrock Adviser, LLC ($26.8M). Based on the latest 13F filings, there are a total of 80 tracked investment funds and institutions maintaining positions in TENX.
What is the overall institutional sentiment toward TENX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $256.8M, driven by 57 managers accumulating shares while 6 reduced their exposure.
Which institutions have been selling or reducing their TENX positions?
In the latest period, 5 funds trimmed their holdings, and 1 managers completely exited their positions. The aggregate reported sell value was $11.1M.
Are there any notable investors adding TENX to their portfolios?
Yes, buying activity remains notable. 31 institutions opened new positions in {ticker}, and 26 existing holders added to their shares. The total reported buy value for the quarter amounted to $304.0M.
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
MSFT
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
View detail
AMZN
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
View detail
NVDA
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter
View detail